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Homotypic/heterotypic fusionAutophagy is an important catabolic pathway that preserves cellular homeostasis. The formation of auto-
phagosomes is a complex process requiring the reorganization of membranes from different compart-
ments. Here we describe methods to analyze SNARE-dependent vesicular fusion events involving the
homotypic and heterotypic fusion of autophagosome precursor structures. These two steps are essential
for the maturation of small single-membrane autophagic precursors containing ATG16L1 and mATG9
proteins into double-membrane autophagosomes. The techniques described in this review are mostly
based on live cell imaging, microscopy, and biochemistry using an in vitro fusion assay, and should help
researchers to study autophagosome biogenesis.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
(Macro) autophagy is a critical clearance pathway for organelles
and long-lived proteins, including intracytoplasmic aggregate-
prone proteins that cause many neurodegenerative diseases, such
as huntingtin in Huntington’s disease, and tau in Alzheimer’s dis-
ease [1]. Autophagosomes are double-membraned structures that
engulf portions of cytoplasm and ultimately fuse with lysosomes,
where their contents are degraded. The ﬁrst recognizable struc-
tures in the pathway are cup-shaped phagophores, whose edges
extend and fuse to form autophagosomes [2,3]. The ATG5–
ATG12/ATG16L1 complex regulates the initiation of phagophore
formation, while phosphatidylethanolamine-conjugated ATG8/
LC3 (LC3-II) mediates the elongation and fusion of the phagophore
edges to form autophagosomes [2,3]. The ATG5–ATG12/ATG16L1
complex decorates the phagophore and dissociates after comple-
tion of autophagosome formation, while LC3-II is localized both
to the phagophore and fully formed autophagosomes.
Clathrin-mediated endocytosis regulates autophagy by enabling
membrane delivery to ATG5/ATG12/ATG16L1-positive phagophore
precursor vesicles (LC3-negative), which mature to form phago-
phores (ATG16L1-positive and LC3-positive), and subsequently
into autophagosomes (ATG16L1-negative and LC3-positive) [4].
The ATG16L1-positive/LC3-negative phagophore precursors
undergo homotypic fusion events that increase their size andenhance their ability to acquire LC3-II [5]. These fusion events
are mediated by SNAREs (an acronym derived from ‘‘SNAP (Soluble
NSF Attachment Protein) REceptors’’), including VAMP7, Syntaxin
7, Syntaxin 8 and Vti1B [5]. The maturation of the ATG16L1-posi-
tive precursors also requires VAMP3-mediated fusion with
mATG9-positive vesicles [6]. Interestingly, VAMP3 depletion does
not affect ATG16L1 homotypic fusion [6]. Currently, it is not clear
if these homotypic and heterotypic fusion events are sequential
or parallel. However, these data reveal that the SNARE-dependent
fusion of distinct vesicles containing different autophagy proteins
is required for optimal autophagosome biogenesis. Interestingly,
these fusions occur prior to the phagophore stage.
We observed that ATG16L1 and mATG9 both trafﬁc via the
plasma membrane. However, they are located in distinct clath-
rin-coated pits and are internalized and trafﬁcked through largely
different routes [6]. mATG9 follows the transferrin receptor path-
way through early endosomes and recycling endosomes, whereas
ATG16L1 reaches the recycling endosomes but has negligible asso-
ciation with early endosomes. The two different pools of vesicles
carrying mATG9 and ATG16L1 coalesce in the recycling endosomes
at a stage prior to phagophore formation [6]. If one inhibits this
process by knocking down VAMP3, then autophagosome formation
is impaired (Fig. 1).
We recently identiﬁed PICALM (CALM; phosphatidylinositol
binding clathrin assembly protein), recently associated with Alz-
heimer’s disease, as an important regulator of both the homotypic
fusion and the heterotypic fusion of autophagic precursors [7]. This
can be attributed to its role as a clathrin adaptor which mediates
the endocytosis of various SNAREs, including VAMP2, VAMP3 and
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SNARE involved in autophagosome formation) is no longer present
on ATG16L1 vesicles resulting in impaired homotypic fusion of
ATG16L1 vesicles; and VAMP3 is no longer associated with mATG9,
which impairs the heterotypic fusion of ATG16L1 and mATG9 ves-
icles (Fig. 1 – in the box) [7]. The downregulation of autophagy
when CALM expression was modiﬁed was also associated with a
decrease in the clearance of tau, a autophagy substrate which is
a key hallmark of Alzheimer’s disease [7].
In this review, we will describe methods to analyze the homo-
typic fusion of ATG16L1 vesicles and the heterotypic fusion of
ATG16L1 and mATG9 vesicles. This is mostly based on live cell
imaging and an in vitro fusion assay, which will be the methods
presented below.2. Protocols
2.1. Homotypic fusion of ATG16L1 vesicles
2.1.1. Live cells imaging
Seed cells (HeLa) into a 35 mm MatTek dish (MatTek Corpora-
tion) at 1  105 cells per dish. Transfect cells with GFP–ATG16L1
plasmid 24 h before imaging using TransIT2020 transfection
reagent (Mirus), according to the manufacturer’s protocol. We
use 300 ng per 6 well dish to minimize overexpression artifacts.
The day after transfection, autophagy can be stimulated by amino
acid- and serum-starvation in Hanks balanced salt solution (HBSS;
Sigma) for 1–4 h. This greatly facilitates the analysis, since it
induces the production of autophagic precursors, facilitating their
detection by microscopy. The dish is then mounted on a live cell
imaging system (Zeiss LSM710) with a CO2 incubation chamber.
Acquisition is done at maximal camera speed for 5–10 min with
minimal exposure in order to avoid photobleaching. A movie is cre-
ated and analyzed manually to score homotypic fusion between
ATG16L1 vesicles. Fused vesicles are scored when two vesicles
are in contact for more than 10 frames. Note that one should
exclude any cells with obviously clumped ATG16L1 structures,
which are likely artifacts.PM: plasma membrane
CCS: clathrin-coated structure
EE: early endosome
PAS: preautophagosomal structure
Fig. 1. Schematic diagram of mAT2.1.2. Fixed cell imaging
Homotypic fusion between ATG16L1 vesicles increases their
size that can be measured by microscopy. Place 13  13 mm
square coverslips into the bottom of each well of a 6 well plate
and seed cells into these plates at 1  105 cells per well. The con-
ﬂuency of the cells at this stage is critical, as too high a density will
preclude automatic counting of vesicles, since the microscope will
be not able to focus properly on the cells. As for live cells imaging,
the day after seeding, autophagy can be stimulated by treating the
cells with HBSS for 1–4 h to induce the production of autophagic
precursors, facilitating their detection by microscopy [4]. Fix the
cells with 4% paraformaldehyde in PBS for 5 min. Wash the cells
three times with PBS. Mount the cells on slides using antifade
reagents (ProLong, Invitrogen). If you have access to the Cellomics
ArrayScan VTI HCS Reader, use the Spot Detector Bioapplication
protocol version 3 to count the number of vesicles per cell and to
measure the size of the vesicles. If you do not have an automatic
microscope, ImageJ is an alternative. To measure the size of vesi-
cles using ImageJ, take high-resolution pictures of your cells using
a confocal microscope. Open your pictures in ImageJ, split the
channels, invert the picture to have white background, adjust the
threshold to take off the background, apply the threshold, open
analyze particles in analyze option, apply and you have a table
with the number of vesicle and their size. We used both methods
to assess ATG16L1 or autophagic vesicle sizes. The Thermo Scien-
tiﬁc Cellomics ArrayScan VTI HCS has a resolution of around
400 nm whereas quantiﬁcation using ImageJ from confocal pic-
tures has a resolution of 150 nm. For these experiments, one
should inspect cells prior to automated imaging to ensure that
any clumped ATG16L1 is minimal, as should be the case if cells
are transfected with low amounts of the plasmid, as described
above.
2.1.3. In vitro fusion assay
This assay was modiﬁed from the method described by Barysch
et al. [8] for analyzing endosome docking/fusion and sorting/bud-
ding, based on labeling of endosomes by endocytotic uptake with
ﬂuorescent cargoes. We adapted this protocol to describe and mea-
sure homotypic fusion of autophagic precursors. Two differentG9 and ATG16L1 itineraries.
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Fig. 2. Homotypic fusion between ATG16L1 vesicles in vivo.
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Fig. 3. Size of ATG16L1 vesicles in VAMP7 and Syntaxin7 knockdown cells.
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mStrawberry–ATG16L1 or GFP–ATG16L1. Two postnuclear super-
natants (PNS) were obtained by mechanical disruption. Transfec-
ted HeLa cells were scraped in 500 ll HB buffer (Homogenization
Buffer: 250 mM sucrose and 3 mM imidazole, pH 7.4 (with HCl)
and proteases inhibitors) and disrupted by vortexing for 1 min in
the presence of glass beads (1:1) (acid-washed 425–600 lm). The
mechanically disrupted cells were centrifuged for 15 min at
1200 rcf at 4 C. The supernatant was collected and 20 ll were
mixed for 60 min in the presence of an ATP regenerative system
(10: DHM buffer: 625 mM HEPES, 75 mM magnesium acetate
and 10 mM DTT (pH 7.4, with KOH), 1 M potassium acetate,
100 mM ATP, 800 mM creatine phosphate, 4 mg ml1 creatine
kinase (=3200 U ml1), 250 mM glucose and 100 mM ATP) at
37 C (a control sample was left on ice) in low adhesive Eppendorf
tubes in a total volume of 30 ll. After the reaction, the samples
were ﬁxed with 2% paraformaldehyde in PBS for 15 min (1:1 with
4% PFA), centrifuged to remove the ﬁxative (13,000 rpm 5 min), re-
suspended in distilled water and mounted with Mowiol 4-88 with
DAPI on glass coverslips for confocal observation. DAPI staining
was used assist focusing on the coverslip.
2.2. Heterotypic fusion of ATG16L1 and ATG9A vesicles
2.2.1. In vitro fusion assay of ATG16L1 and mATG9 vesicles
As described above, the quantiﬁcation of homotypic fusion
between ATG16L1 and ATG16L1 vesicles is an important parame-
ter to enable characterization of this early event of autophagosome
biogenesis. The approach described above can be easily applied to
measure heterotypic fusion of ATG16L1/mATG9 carrying vesicles.HeLa cells are transfected for 20 h with mStrawberry–ATG16L1
or mATG9–GFP and we followed the same protocol described
above for homotypic fusion in Section 2.1.3.2.2.2. Colocalisation of ATG16L1 and mATG9 vesicles
HeLa cells silenced or not for VAMP3 for 72 h using siRNAs
(100 nmol of SMARTpool_L-011934-00 from Dharmacon; using
Lipofectamine2000 reagent from Invitrogen) were transfected with
mStrawberry–ATG16L1 for 20 h (using TransIT2020 reagent from
Mirus) and grown on coverslips at conﬂuencies of 25%. The cells
were then ﬁxed in 4% paraformaldehyde for 5 min and then perme-
abilised with 0.1% Triton. Fixed cells were incubated with anti-
mATG9 antibody (ABCAM; Rabbit monoclonal [EPR2450(2)]), 1%
BSA in PBS, followed by secondary antibody in the same buffer.
Alternatively, HeLa cells transfected with mStrawberry–ATG16L1
for 20 h were left at 37 C or placed at 18 C for 4 h. Fixed cells were
incubated with anti-mATG9 antibody (ABCAM), 1% BSA in PBS, fol-
lowed by secondary antibody in the same buffer. A Zeiss LSM710
confocal microscope was used for ﬂuorescent confocal analysis.
All confocal images were taken with a 63 oil-immersion lens.
Volocity software (PerkinElmer) was used for colocalisation analy-
sis using Pearson’s Coefﬁcient (or Manders’ Coefﬁcient) and pro-
cessing of confocal images. The Pearson’s Coefﬁcient was used to
measure the correlation between the signals from two different
markers/proteins. The Manders’ Coefﬁcient was used to quantify
the localisation of protein A in compartment B under different con-
ditions. A minimum of 20 cells were examined each condition. All
experiments are repeated at least three times. The background was
ﬁxed for all within-experiment analyzes (for Mander’s).
AB
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Fig. 4. Homotypic fusion between ATG16L1 vesicles in vitro.
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Fig. 5. Heterotypic fusion between ATG16L1 and mATG9 vesicles in vitro.
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HeLa cells were seeded on MatTek Petri dish (MatTek, Ashland,
MA, USA) at a density of approximately 1.5  105 cells per dish and
transfected with mATG9–GFP and mStrawberry–ATG16L1. After
20 h, the cells were placed in HBSS (Ca+Mg+) with HEPES, after
which they were imaged immediately at 37 C. Five movies of
5 min were recorded for each experiment. Imaging was performed
on a Zeiss Axiovert 200 M microscope with a LSM 710 confocal
attachment using a 63 1.4 NA Plan Apochromat oil-immersion
lens. The fusion events between ATG16L1 and mATG9 vesicles
were observed in the different movies.
3. Results and discussion
3.1. Homotypic fusion
3.1.1. Live cell imaging
Live cell imaging is probably the best method to observe a
defect in the homotypic fusion of ATG16L1 vesicles and it avoidspotential artifacts due to cell preparation such as ﬁxation or lysis.
We identiﬁed SNAREs, which primarily mediate vesicle fusion, as
important determinants of this process (VAMP7, Syntaxin7, Syn-
taxin8 and Vti1B). Using a SNARE inhibitor called NEM (N-Ethyl
maleimide), that inhibits an ATPase involved in SNAREs-dependent
fusion, we observed a clear defect in the homotypic fusion of
ATG16L1 vesicles (Fig. 2). Moreover, when we stimulated autoph-
agy by rapamycin treatment or by amino acid and serum starva-
tion, we observed an increase in the rate of homotypic fusion
(Fig. 2).3.1.2. Fixed cells imaging
To complement the live cell imaging strategy, we measured the
sizes of ATG16L1 vesicles by microscopy on ﬁxed samples to pro-
vide additional information regarding the maturation of ATG16L1
vesicles. Indeed, the homotypic fusion of ATG16L1 vesicles
increases their size, which can be easily measured using post-
acquisition software, such as the one included in the Cellomics
AB
Fig. 6. Colocalisation by immunoﬂuorescence of ATG16 and ATG9 vesicles.
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version 3. In the example below, the size of ATG16L1 vesicles
decrease in VAMP7 or Syntaxin 7 (Stx7) knockdown cells (Fig. 3),
where fusion is abrogated.3.1.3. In vitro fusion assay
The last method used to study the homotypic fusion of ATG16L1
vesicles is an in vitro fusion assay between different ﬂuorescent
pools of ATG16L1 vesicles. In this assay, the fused vesicles appear
yellow (as the consequence of green and red colocalization) that
can be easily quantiﬁed (Fig. 4). In the example below, we used
the SNARE inhibitor NEM to show a decrease in yellow vesicles
(fused vesicles), indicating a defect in the homotypic fusion of
ATG16L1 vesicles (Fig. 4).3.2. Heterotypic fusion
3.2.1. In vitro fusion assay of ATG16L1 and mATG9 vesicles
The method described above can be also be used to analyze the
heterotypic fusion between ATG16L1 and mATG9 carrying vesicles.
Here we show how this method can be used to analyze the hetero-
typic fusions between ATG16L1 and mATG9 vesicles and provide a
control where the critical SNARE, VAMP3, was depleted. Silencing
of VAMP3 led to a strong decrease of the colocalisation between
the green and red vesicles (Fig. 5).3.2.2. Colocalisation by immunoﬂuorescence of ATG16L1 and mATG9
vesicles
The colocalisation between ATG16L1 and mATG9 can also be
measured in whole cells by classical immunoﬂuorescence and con-
focal analysis. Loss of interaction between the ATG16L1 and
mATG9 compartments was observed again in cells where VAMP3
was silenced, as well as in cells placed for 4 h at 18 C, where the
membrane trafﬁc between the early endosomes and recycling
endosomes was inhibited (Fig. 6).3.2.3. Live imaging of ATG16L1 and mATG9 fusion
Once we identiﬁed VAMP3 as a key element regulating the het-
erotypic fusion between ATG16L1 and mATG9 structures, we stud-
ied cells by live imaging. In basal conditions, one can observe
vesicles carrying ATG16L1 fusing with those with mATG9. In the
absence of VAMP3, the two pools of vesicles approach each other
but never fuse. These experiments explain the decreased colocal-
isation between ATG16L1 and mATG9 that was observed using
the methods described above.
4. Conclusion
In this review, we describe methods to study early steps that
are important for autophagosome formation – the homotypic
fusion of ATG16L1 vesicles and the heterotypic fusion between
ATG16L1 and mATG9 vesicles. These two steps are crucial for
proper maturation of autophagic precursors into phagophores
[5,6] and involve SNAREs. Interestingly, different SNAREs regulate
the homotypic and the heterotypic fusion. VAMP7 and VAMP2
are involved in the homotypic fusion of ATG16L1 vesicles but not
in the heterotypic fusion between ATG16L1 and mATG9 vesicles,
whereas VAMP3 is involved only in the heterotypic fusion [5,6].
Even if we do not know the sequential relationships of the homo-
typic versus the heterotypic fusions (it could happen simulta-
neously), they represent important events. The fact that different
SNAREs are involved suggest that different compartments partici-
pate and coalesce during autophagosome biogenesis. This concept
is consistent with the publications on autophagosome formation
involving different intracellular compartments such as endosomes,
recycling endosomes, Golgi, exocyst, endoplasmic reticulum and
mitochondria [4,6,9–12]. Obviously, these methods have to be used
in combinations with other techniques in order to get a better
insight about the role of a protein in autophagosome formation.
These methods include the measurement of LC3-II by western blot,
electron microscopy, autophagy substrate clearance assays, well
described in many publications [13–15].
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